| Recruiting | The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dys NCT07027826 | National Institute of Allergy and Infectious Diseases (NIAID) | N/A |
| Recruiting | PRospective Registry of Esophageal Motility NCT07506746 | IRCCS San Raffaele | — |
| Recruiting | Utility of Mucosal Impedance Device in Chronic Esophageal Disorders: NCT07227506 | Medical College of Wisconsin | — |
| Recruiting | A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to NCT06851559 | Phathom Pharmaceuticals, Inc. | Phase 2 |
| Recruiting | Prevalence and Description of FIRE (Food Induced Immediate Response of the Esophagus) in the Pediatric Populat NCT06972147 | University Hospital, Angers | — |
| Completed | Comparing the Extent to Which AQ280 is Made Available in the Body After Single Oral Doses of a Capsule Formula NCT07093008 | AQILION AB | Phase 1 |
| Recruiting | Zemaira Eosinophilic Esophagitis Pilot Study NCT05485155 | Children's Hospital Medical Center, Cincinnati | Phase 2 |
| Recruiting | Patient-Centered Decision Support for Eosinophilic Esophagitis NCT06817213 | University of Michigan | N/A |
| Withdrawn | Imaging of the Esophagus Using a SECM Capsule NCT03546660 | Massachusetts General Hospital | N/A |
| Recruiting | Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoE NCT06705387 | University of Colorado, Denver | Phase 2 |
| Recruiting | A Non-interventional Observational Study to Assess Long-term Efficacy and Safety of Dupilumab for the Treatmen NCT06695897 | Sanofi | — |
| Recruiting | Prospective Registry of EoSinophilic esOphagitis NCT06443346 | IRCCS San Raffaele | — |
| Enrolling By Invitation | Dupilumab for Eosinophilic Esophagitis With Severe Strictures NCT06352073 | University of North Carolina, Chapel Hill | Phase 4 |
| Recruiting | EDN and Eosinophilic Esophagitis NCT06387030 | Assistance Publique - Hôpitaux de Paris | N/A |
| Recruiting | Pediatric Eosinophilic Esophagitis (pedEoE): Effect of Allergen Heat Denaturation on EoE Remission: a Pilot Tr NCT06381219 | Universitaire Ziekenhuizen KU Leuven | N/A |
| Unknown | Monocentric Retrospective Observational Study for Validation of Meta-analysis of the Metatrascryptome and Tran NCT06071585 | IRCCS San Raffaele | — |
| Recruiting | Eosinophilic Esophagitis: Towards Improved Management NCT06991881 | Oslo University Hospital | — |
| Not Yet Recruiting | San Raffaele EoE Biobank NCT05896891 | IRCCS San Raffaele | — |
| Unknown | Sensory Processing Issues in Eosinophilic Esophagitis NCT06187753 | Gazi University | — |
| Recruiting | Capsule Sponge Study in Eosinophilic Oesophagitis NCT06501274 | East and North Hertfordshire NHS Trust | N/A |
| Unknown | Validation in French of a Quality of Life Questionnaire for Patients With Eosinophilic Esophagitis in Pediatri NCT05900011 | Fondation Lenval | — |
| Completed | A Study of CDX-0159 in Patients With Eosinophilic Esophagitis NCT05774184 | Celldex Therapeutics | Phase 2 |
| Recruiting | An Intervention Study to Improve Therapeutic Compliance in Adult Patients With Eosinophilic Esophagitis. NCT05730933 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | N/A |
| Recruiting | A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE). NCT05608681 | Eupraxia Pharmaceuticals Inc. | Phase 1 / Phase 2 |
| Completed | Mesalazine Oral Suspension in Active Eosinophilic Esophagitis NCT05488405 | Dr. Falk Pharma GmbH | Phase 2 |
| Completed | A Study to Investigate Safety and Tolerability of NDX-3315 and NDX-3324 in Healthy Participants and Patients W NCT05757856 | NexEos Diagnostics, Inc. | Phase 2 |
| Completed | 24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3) NCT05634746 | Ellodi Pharmaceuticals, LP | Phase 3 |
| Completed | A Study of Baked Milk Tolerance to Treat Eosinophilic Esophagtis NCT05606705 | Mayo Clinic | N/A |
| Completed | Evaluation of Efficacy, Safety and Patient' Satisfaction of Therapeutic Switch From Off-Steroids to Budesonide NCT05594849 | Istituto Clinico Humanitas | — |
| Terminated | Systems Biology of Gastrointestinal and Related Diseases NCT05579444 | Viome | — |
| Active Not Recruiting | Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis NCT05583227 | AstraZeneca | Phase 3 |
| Unknown | Eosinophilic Oesophagitis Assessment With String Testing NCT06159218 | St George's, University of London | N/A |
| Active Not Recruiting | The Immune Directed Individualized Elimination Therapy (iDIET) Study NCT05543512 | University of North Carolina, Chapel Hill | N/A |
| Completed | A Study of Detergents in the Pathogenesis of Eosinophilic Esophagitis NCT05482256 | Mayo Clinic | N/A |
| Unknown | Evaluating Adrenal Insufficiency in Adults With Eosinophilic Esophagitis on Chronic Swallowed Topical Steroids NCT05246085 | University of Colorado, Denver | — |
| Completed | Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis NCT04991935 | Celgene | Phase 3 |
| Unknown | The Efficacy and Tolerability of 12-weeks Treatment With Almond and Buckwheat Based Formula in Pediatric Patie NCT05622214 | Rambam Health Care Campus | N/A |
| Completed | Efficacy of Dupilumab on Facilitated Food Introduction in Eosinophilic Esophagitis NCT05247866 | Children's Hospital of Philadelphia | Phase 4 |
| Completed | A Study Evaluating Potential Disease-Mediated Drug-Drug Interaction in Adult Participants With Active Eosinoph NCT05175352 | Celgene | Phase 1 |
| Unknown | Comparison of Histology From a Mesh Sponge and Traditional Esophageal Biopsies in Children and Adolescents Wit NCT05342168 | The Hospital for Sick Children | N/A |
| Unknown | Targeted Elimination Diet in EoE Patients Following Identification of Trigger Nutrients Using Confocal Laser E NCT05695456 | Universitaire Ziekenhuizen KU Leuven | Phase 1 / Phase 2 |
| Withdrawn | Safety and Pharmacokinetics of Orodispersible BT-11 in Active Eosinophilic Esophagitis NCT04835168 | NImmune Biopharma | Phase 1 |
| Recruiting | National, Multicenter, Retrospective, Prospective Study to Evaluate Pediatric Gastrointestinal Eosinophilic Di NCT05219903 | Fondazione IRCCS Policlinico San Matteo di Pavia | — |
| Completed | Cycling of Topical Steroids for Treatment of EoE (Eosinopilic Esophagitis) NCT05444543 | University Hospitals Cleveland Medical Center | Phase 4 |
| Completed | A Study to Assess the Efficacy, Safety and Tolerability of IRL201104 in Adults With Active Eosinophilic Esopha NCT05084963 | Revolo Biotherapeutics | Phase 2 |
| Completed | Efficacy and Safety APT-1011 in Adolescent Subjects With Eosinophilic Esophagitis (EoE) - A Sub-Study of the F NCT05083312 | Ellodi Pharmaceuticals, LP | Phase 3 |
| Completed | A Study to Investigate the Efficacy and Tolerability of ESO-101 in Patients With Eosinophilic Esophagitis NCT04849390 | EsoCap AG | Phase 2 |
| Withdrawn | Non-endoscopic Tracking of Disease Activity in Eosinophilic Esophagitis NCT03834298 | University of Colorado, Denver | N/A |
| Recruiting | Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE NCT06596252 | Dr. Falk Pharma GmbH | Phase 3 |
| Withdrawn | Pharmacokinetics, Efficacy, Tolerability and Safety of Different Budesonide Oral Gel Doses in Adults' Subjects NCT05214599 | Bazell Pharma AG | Phase 2 |
| Unknown | Efficacy and Safety of Three Doses of Florence Oral Suspension in Adults With Eosinophilic Esophagitis NCT02873468 | EMS | Phase 2 |
| Unknown | Endoscopic Characterisation of Inflammation in EoE NCT04769232 | University of Zurich | N/A |
| Completed | A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Participants With Eosinophilic NCT04753697 | Celgene | Phase 3 |
| Unknown | Survey About the Relationship Beetween Allergic Rhinitis and Seasonal EOE Exacerbations NCT05755477 | Nucera Eleonora | — |
| Recruiting | Eosinophilic Gastrointestinal Disorders Registry NCT05199532 | Ann & Robert H Lurie Children's Hospital of Chicago | — |
| Completed | A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagiti NCT04682639 | Pfizer | Phase 2 |
| Completed | Identification of Autoantigens in EGPA and Severe Eosinophilic Asthma NCT04671446 | Queen Mary University of London | — |
| Recruiting | Tolerability of Goat Milk Protein in Eosinophilic Esophagitis Patients With Cow Milk Protein Trigger NCT05180578 | Shaare Zedek Medical Center | N/A |
| Active Not Recruiting | Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis Assessed by Transnasal Endoscopy (TNE) NCT04149470 | University of Colorado, Denver | Phase 4 |
| Completed | Dose Escalation Study to Evaluate an Experimental New Treatment (CALY-002) in Healthy Subjects and Subjects Wi NCT04593251 | Calypso Biotech BV | Phase 1 |
| Terminated | A Study of Benralizumab in Patients With Eosinophilic Esophagitis NCT04543409 | AstraZeneca | Phase 3 |
| Completed | The Use of Fractionated Exhaled Nitric Oxide in the Diagnosis and Assessment of Disease Activity of Eosinophil NCT04941742 | The University of Texas Health Science Center, Houston | — |
| Completed | Pilot Study of Esocheck in Eosinophilic Esophagitis NCT04311970 | University of Pennsylvania | N/A |
| Terminated | Antihistamines in Eosinophilic Esophagitis NCT04248712 | Mayo Clinic | Phase 2 |
| Completed | A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Esophagitis NCT04322708 | Allakos Inc. | Phase 2 / Phase 3 |
| Completed | Swallowing Characteristics of Pediatric Patients With Eosinophilic Esophagitis NCT04704752 | Gazi University | — |
| Completed | Efficacy and Safety APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2) NCT04281108 | Ellodi Pharmaceuticals, LP | Phase 3 |
| Withdrawn | Metabolomic Profiling of Eosinophilic Esophagitis NCT03803527 | University of Colorado, Denver | N/A |
| Completed | Eosinophilic Esophagitis Steroid Safety Study NCT04416217 | Rabin Medical Center | — |
| Completed | Somatization, Anxiety, and Disordered Sleep in Pediatric Eosinophilic Esophagitis NCT04309786 | University of California, San Diego | — |
| Completed | Mepo for Eosinophilic Esophagitis (EoE) Study NCT03656380 | University of North Carolina, Chapel Hill | Phase 2 |
| Recruiting | Characteristics and Inflammatory Markers in Children with Eosinophilic Esophagitis (EoE) NCT03980886 | University of California, San Diego | — |
| Completed | The Use of Fractionated Exhaled Nitric Oxide in the Diagnosis and Assessment of Disease Activity of Eosinophil NCT03812575 | The University of Texas Health Science Center, Houston | — |
| Unknown | Prospective Multicenter Nationwide Registry of Children With Eosinophilic Esophagitis NCT03858426 | Sociedad Espanola de Gastroenterologia, Hepatologia y Nutricion Pediatrica | — |
| Completed | A Food Additive Removal Diet for Pediatric Eosinophilic Esophagitis NCT03657771 | Nemours Children's Clinic | N/A |
| Unknown | EoE RCT Fluticasone and Omeprazole vs Fluticasone Alone NCT03781596 | Claire Daniels | Phase 4 |
| Completed | Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Eso NCT03633617 | Regeneron Pharmaceuticals | Phase 3 |
| Completed | CEGIR 7807: Validation of Online Cohort of EGID Patients Enrolled in RDCRN CEGIR Contact Registry NCT03382678 | Children's Hospital Medical Center, Cincinnati | — |
| Withdrawn | EoE Food Desensitization NCT02881372 | The University of Texas Health Science Center, Houston | N/A |
| Completed | Innate Immunity in Eosinophilic Esophagitis NCT03640975 | Assistance Publique - Hôpitaux de Paris | — |
| Completed | Use of Esophageal String Test to Understand Symptoms, Inflammation, and Function in Eosinophilic Esophagitis NCT03305653 | University of Colorado, Denver | N/A |
| Withdrawn | Effects of Swallowed Steroids on Bone Density and Growth in Pediatric Eosinophilic Esophagitis NCT03615950 | Arkansas Children's Hospital Research Institute | — |
| Unknown | The Role of HRM and Specific Biomarkers of Inflammation in the Diagnosis of Patients With Dysphagia and Suspec NCT04803162 | Wroclaw Medical University | — |
| Completed | Mucosal Impedance Balloon in Diagnosis and Treatment of Eosinophilic Esophagitis (EoE) NCT02995395 | Mayo Clinic | — |
| Completed | CEGIR 7808: Use of Unsedated Transnasal Esophagoscopy (TNE) to Monitor Dietary Management of Eosinophilic Esop NCT03342391 | Children's Hospital Medical Center, Cincinnati | N/A |
| Recruiting | A Registry for the Food Allergy Community NCT04653324 | Food Allergy Research & Education | — |
| Withdrawn | Short Duration 6Fed Sponge For EoE Patients NCT03354221 | Mayo Clinic | N/A |
| Completed | Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) NCT03191864 | Adare Pharmaceuticals, Inc. | Phase 2 |
| Completed | Natural History of Eosinophilic Esophagitis NCT03290482 | Mayo Clinic | — |
| Completed | An Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE) NCT03029091 | Children's Hospital Medical Center, Cincinnati | Phase 2 |
| Completed | Metabolomics for Biomarker Discovery in Children With EoE NCT03107819 | The University of Texas Health Science Center, Houston | — |
| Completed | Sponge and Eosinophil Peroxidase (EPO) Staining NCT03078023 | Mayo Clinic | N/A |
| Terminated | MRI to Assess Fibrosis in Eosinophilic Esophagitis Patients NCT03446118 | Mayo Clinic | N/A |
| Recruiting | Changes in Esophageal Distensibility With Proton Pump Inhibitors in Patients With Esophageal Eosinophilia: A P NCT03312686 | Indiana University | — |
| Completed | Eosinophil β1 Integrin Activation as a Biomarker for Eosinophilic Esophagitis NCT02775045 | University of Wisconsin, Madison | — |
| Completed | Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort NCT02897271 | Children's Hospital Medical Center, Cincinnati | — |
| Completed | Radiation Dose in Humans From Orally Administered Tc99m-Heparin NCT04069429 | University of Utah | EARLY_Phase 1 |
| Completed | Application of a Novel Allergen-Specific Immune Signature Directed Approach to Dietary Elimination Therapy in NCT02722148 | University of North Carolina, Chapel Hill | N/A |
| Completed | Eosinophilic Esophagitis Intervention Trial-1 Food vs. 4 Food Elimination Diet Followed by Swallowed Glucocort NCT02610816 | Children's Hospital Medical Center, Cincinnati | Phase 2 / Phase 3 |
| Completed | a4b7 Integrin in Eosinophilic Esophagitis NCT02546219 | Massachusetts General Hospital | — |
| Completed | Maintenance of Remission With Budesonide Orodispersible Tablets vs. Placebo in Eosinophilic Esophagitis NCT02493335 | Dr. Falk Pharma GmbH | Phase 3 |
| Completed | Budesonide Orodispersible Tablet vs. Placebo in Active Eosinophilic Esophagitis NCT02434029 | Dr. Falk Pharma GmbH | Phase 3 |
| Completed | Cytosponge and Dietary Therapy in EoE NCT02599558 | Mayo Clinic | N/A |
| Completed | Milk Patch for Eosinophilic Esophagitis NCT02579876 | Children's Hospital of Philadelphia | Phase 2 |
| Recruiting | Natural History and Genetics of Food Allergy and Related Conditions NCT02504853 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Recruiting | OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages NCT02523118 | Children's Hospital Medical Center, Cincinnati | — |
| Terminated | Diagnosis and Monitoring of Eosinophilic Esophagitis Using the Cytosponge NCT02114606 | University of North Carolina, Chapel Hill | N/A |
| Completed | Study of Dupilumab in Adult Participants With Active Eosinophilic Esophagitis (EoE) NCT02379052 | Regeneron Pharmaceuticals | Phase 2 |
| Completed | Food Antigen in Eosinophilic Esophagitis NCT02434705 | Mayo Clinic | — |
| Completed | Phenotypic Characterization and Biomarkers Investigation for Eosinophilic Esophagitis in Pediatric Patients NCT03069573 | Federal University of Uberlandia | — |
| Completed | The Effect of Sucralfate Slurry in Patients With Eosinophilic Esophagitis NCT02353078 | Mayo Clinic | EARLY_Phase 1 |
| Completed | Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis NCT02019758 | University of North Carolina, Chapel Hill | Phase 4 |
| Unknown | Fibrostenotic Eosinophilic Esophagitis: Assessment Tools NCT02453126 | University of Colorado, Denver | — |
| Completed | Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis NCT02371941 | University of Tennessee | Phase 4 |
| Terminated | EndoFLIP Use in Upper GI Tract Stenosis NCT02354716 | University of Pennsylvania | — |
| Recruiting | Indiana University Gastrointestinal Motility Diagnosis Registry NCT04506593 | Indiana University | — |
| Terminated | Esophageal Absorption in EoE NCT02314455 | Mayo Clinic | N/A |
| Completed | Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis NCT02098473 | Celgene | Phase 2 |
| Completed | Value of Patch Testing in Direct Diet Therapy for Eosinophilic Esophagitis NCT02227836 | Mayo Clinic | N/A |
| Active Not Recruiting | Efficacy of Low-Dose Topical Steroids in Maintaining Remission of Eosinophilic Esophagitis in Children NCT05309590 | Ann & Robert H Lurie Children's Hospital of Chicago | — |
| Terminated | Mometasone-furoate for Treatment of Eosinophilic Esophagitis - a Randomized Placebo Controlled Study. NCT02113267 | Mogens Bove | Phase 2 |
| Completed | EoE(Eosinophilic Esophagitis) NCT01999439 | University of Michigan | N/A |
| Completed | Comparison of Esophageal Clearance Times of Oral Budesonide Preparations NCT02125851 | Walter Reed National Military Medical Center | N/A |
| Completed | Testing Effectiveness of Losartan in Patients With EoE With or Without a CTD NCT01808196 | Children's Hospital Medical Center, Cincinnati | Phase 2 |
| Unknown | Esophageal Motility in Eosinophilic Esophagitis Evaluated by High Resolution Manometry. NCT02331849 | Technical University of Munich | N/A |
| Active Not Recruiting | Using Spectrally Encoded Confocal Microscopy (SECM) to Image the Esophagus NCT02202590 | Massachusetts General Hospital | N/A |
| Completed | Mucosal Impedance and Eosinophilic Esophagitis NCT01953575 | Mayo Clinic | N/A |
| Completed | Nasal Nitric Oxide Levels in Eosinophilic Esophagitis (EoE) NCT01929824 | Mayo Clinic | — |
| Terminated | Eosinophilic Esophagitis Clinical Therapy Comparison Trial NCT01821898 | Baylor College of Medicine | Phase 2 |
| Completed | Assessing Risk of Food Insecurity Within Households of Children With Food Allergy NCT01897506 | Arkansas Children's Hospital Research Institute | — |
| Terminated | Sirolimus for Eosinophil-Associated Gastrointestinal Disorders NCT01814059 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Active Not Recruiting | Morphological Markers of Gastroesophageal Reflux Disease (GERD) NCT01921686 | Baylor College of Medicine | — |
| Withdrawn | Eosinophilic Gastrointestinal Disorders Patient Registry NCT01779154 | Arkansas Children's Hospital Research Institute | — |
| Terminated | Cytosponge Protocol IRB 11-006429 NCT01585103 | Mayo Clinic | N/A |
| Completed | Registry for Eosinophilic Gastrointestinal Disorders (REGID) NCT01382563 | Children's Hospital Medical Center, Cincinnati | — |
| Completed | Dietetic Versus Topical Steroids for Pediatric Eosinophilic Esophagitis NCT01846962 | Azienda Policlinico Umberto I | Phase 4 |
| Completed | Intestinal Permeability in Response to Treatment in Eosinophilic Esophagitis Patients NCT01641913 | Mayo Clinic | Phase 1 |
| Withdrawn | Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis NCT01479231 | Mayo Clinic | Phase 1 / Phase 2 |
| Active Not Recruiting | Cow's Milk Elimination for Treatment of Eosinophilic Esophagitis NCT05083156 | Ann & Robert H Lurie Children's Hospital of Chicago | — |
| Completed | Study to Image the Esophagus Using the OFDI Capsule NCT02204150 | Massachusetts General Hospital | N/A |
| Completed | A Six Month, Safety Follow-up Study in Eosinophilic Esophagitis Subjects Who Completed Study PR-021 NCT01498497 | Forest Laboratories | — |
| Withdrawn | Eosinophilic Esophagitis Treatment: Montelukast vs Fluticasone NCT01702701 | Medical College of Wisconsin | Phase 3 |
| Terminated | A Trial of Montelukast for Maintenance Therapy of Eosinophilic Esophagitis in Children NCT01458418 | Children's Mercy Hospital Kansas City | N/A |
| Active Not Recruiting | Prospective Database for Eosinophilic Esophagitis (EoE) of Pediatric Population NCT05176249 | Ann & Robert H Lurie Children's Hospital of Chicago | — |
| Completed | Safety and Tolerability Study of Oral EUR-1100 to Treat Eosinophilic Esophagitis NCT01386112 | Forest Laboratories | Phase 1 / Phase 2 |
| Completed | Improved Diagnostics of Celiac Disease in Children NCT02072590 | Tampere University Hospital | — |
| Active Not Recruiting | Risk Factors and Biomarkers for Diagnosis and Treatment of EoE NCT01988285 | University of North Carolina, Chapel Hill | — |
| Active Not Recruiting | A Prospective Study of the Four Food Elimination Diet for Treatment of Eosinophilic Esophagitis NCT05176262 | Ann & Robert H Lurie Children's Hospital of Chicago | — |
| Completed | Budesonide Effervescent Tablets vs. Viscous Budesonide Suspension vs. Placebo in Eosinophilic Esophagitis NCT02280616 | Dr. Falk Pharma GmbH | Phase 2 |
| Completed | Prevalence of Food Allergies in a Cohort of Adult Patients With Eosinophilic Esophagitis NCT01631591 | University of South Florida | — |
| Completed | Eosinophilic Esophagitis Databank NCT01323803 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Prevalence of Eosinophilic Esophagitis in Children With Celiac Disease NCT02190513 | St. John Health System, Michigan | — |
| Active Not Recruiting | Inflammatory Mediators as Potential Non-Invasive Biomarkers in Subjects With Eosinophilic Esophagitis NCT03822325 | Ann & Robert H Lurie Children's Hospital of Chicago | — |
| Enrolling By Invitation | Molecular Basis of Food Allergy NCT01832324 | Children's Hospital of Philadelphia | — |
| Unknown | New Serological Markers for Eosinophilic Esophagitis NCT01624129 | Technical University of Munich | — |
| Completed | Confocal Laser Endomicroscopy in Patients With Eosinophilic Esophagitis NCT01234376 | University of Erlangen-Nürnberg Medical School | — |
| Terminated | Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal Disorders NCT01212016 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Exhaled Nitric Oxide as a Biomarker of Disease Activity in Eosinophilic Esophagitis NCT01170234 | Tufts Medical Center | — |
| Completed | Proof of Concept Study of OC000459 in Eosinophilic Esophagitis NCT01056783 | Oxagen Ltd | Phase 2 |
| Completed | A Randomized Double Blind Placebo Controlled Study of the Effect of Swallowed Beclomethasone Dipropionate on I NCT01016223 | Penn State University | Phase 1 |
| Completed | Comparing Anesthetic Techniques in Children Having Esophagogastroduodenoscopies NCT02038894 | Children's Hospital Medical Center, Cincinnati | N/A |
| Completed | Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis NCT01022970 | Novartis Pharmaceuticals | Phase 2 |
| Completed | Topical Budesonide Treatment for Eosinophilic Esophagitis (EoE) NCT00961233 | University of North Carolina, Chapel Hill | N/A |
| Completed | Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model NCT01040598 | O & O Alpan LLC | Phase 1 |
| Unknown | Esophageal String Test in Eosinophilic Esophagitis NCT02008903 | University of Colorado, Denver | — |
| Completed | Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis NCT00635089 | Ception Therapeutics | Phase 3 |
| Completed | The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis NCT00728481 | Mayo Clinic | Phase 2 / Phase 3 |
| Completed | Fluticasone Versus Esomeprazole to Treat Eosinophilic Esophagitis NCT00895817 | Walter Reed Army Medical Center | N/A |
| Completed | Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years NCT00538434 | Ception Therapeutics | Phase 2 / Phase 3 |
| Completed | Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis NCT00638456 | Ranjan Dohil | Phase 2 |
| Completed | Eosinophilic Esophagitis: Influence of Dilation on Dysphagia and Inflammation NCT00667524 | University of Bern | — |
| Terminated | The Frequency of Eosinophilic Esophagitis in Patients With Heartburn That is Refractory to Proton Pump Inhibit NCT01404832 | Dallas VA Medical Center | Phase 4 |
| Completed | Trial of Montelukast in Eosinophilic Esophagitis NCT00511316 | Mayo Clinic | Phase 1 |
| Completed | A Study of Flovent in Patients With Eosinophilic Esophagitis NCT00426283 | Marc Rothenberg, MD | Phase 2 |
| Completed | Budesonide for Eosinophilic Esophagitis NCT00271349 | Swiss EE Study Group | Phase 2 |
| Completed | Topical Steroid Treatment for Eosinophilic Esophagitis NCT00275561 | Mayo Clinic | Phase 2 |
| Completed | A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders NCT00266578 | Marc Rothenberg | Phase 3 |
| Completed | Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome NCT00266565 | Children's Hospital Medical Center, Cincinnati | Phase 1 / Phase 2 |
| Completed | Data Bank for Eosinophilic Disorders NCT00267475 | Marc Rothenberg | — |
| Withdrawn | Allergy Immunotherapy in the Management of Eosinophilic Esophagitis NCT01685034 | United States Naval Medical Center, San Diego | N/A |
| No Longer Available | Expanded Access Protocol for Patients With Eosinophilic Esophagitis NCT05095116 | Ellodi Pharmaceuticals, LP | — |